"Much as they do in managing their own health care, people need to weigh the benefits and risks of a drug prescribed for their pet." --Bren, Linda. Prescriptions for Healthier Animals: Pets and People Frequently Fight Disease with Similar Drugs. FDA Consumer Magazine, Nov-Dec 2000.
|
"In recent years, the demand for drugs for companion animals - in particular, dogs and cats - has significantly increased, driven in part by an ageing pet population and a greater willingness of owners to pay for effective treatments. (In fact, of the seven drugs with annual sales greater than US $100 million introduced in the past decade, five are for companion animals.) This has created opportunities both for novel drug development and for the crossover of drugs developed for humans... The use of non-steroidal anti-inflammatory drugs for canine arthritis is an example of how animal drug development can mirror new drug development for humans. Today, more than half of all commercially led pharmaceutical research and development in the veterinary field is focused on developing products for companion animals, and the emphasis on this sector looks likely to increase in coming years, as companion animals live longer, and more diseases of old age are being diagnosed and treated." |
What is here? | |||
|
|
|
|
|
|
|
| |
|
|
||
|
|
next page | |
|
|
||